eznews.inNew guidelines from the British Dietetic Association (BDA) recommend dietary interventions to alleviate chronic constipation, which affects up to 20% of adults in the U.S. The guidelines, developed after analyzing 75 clinical trials, suggest that consuming two to three kiwifruits daily, along with high mineral-content water and rye bread, can significantly improve bowel health. Kiwifruit, noted for its high fiber content and the enzyme actinidin, is particularly effective in increasing stool frequency. The BDA emphasizes the importance of evidence-based recommendations, having established 59 statements on dietary approaches, while advising against reliance on probiotics and senna supplements due to limited efficacy. Experts in the field have praised the guidelines for providing clear, actionable advice, moving beyond generic recommendations to specific foods and strategies, thus empowering individuals to manage their symptoms effectively. 
Published: Oct 18 2025, 12 ameznews.inAs the Medicare open enrollment period unfolds, experts emphasize the importance for beneficiaries to evaluate their coverage options for 2026, amid anticipated changes in costs and services. Monthly premiums for Medicare Part B are expected to rise by 12% from $185 to $206, while some Medicare Advantage plans may see a decrease in premiums from $16 to $14. Additionally, the annual deductible for Part B is projected to increase by 12% to $288. There are concerns regarding the impact of a potential government shutdown on claims processing and telehealth services, which could further complicate access to care for vulnerable populations. With around 69 million Americans relying on Medicare, experts warn that many recipients do not currently compare plans, potentially missing out on savings. Whitney Stidom of eHealth advises beneficiaries to utilize resources to explore their options thoroughly during this critical enrollment period.
Published: Oct 17 2025, 9 pmeznews.inA recent study suggests that two widely used heart medications, pemafibrate and telmisartan, may reverse fatty liver disease, known as metabolic dysfunction-associated steatotic liver disease (MASLD), in animal models. MASLD affects nearly 40% of adults globally and can progress to severe liver conditions if untreated. The research, published in *Pharmacological Research*, found that both drugs significantly reduced fat accumulation in the liver of rats and zebrafish larvae, with a combination of the two proving as effective as higher doses of each individually. The study's lead author, Marta Alegret, emphasized the importance of further clinical trials to validate these findings in humans before recommending their use for treating MASLD. Experts highlight the potential benefits of repurposing existing medications, given their established safety profiles, to address this growing health concern.
Published: Oct 16 2025, 1 pmeznews.inA recent study published in *The Lancet Healthy Longevity* has revealed that quitting smoking, even in midlife or later, can significantly slow down age-related cognitive decline. Researchers analyzed data from 4,718 adults aged 40 to 89 who quit smoking, comparing them to an equal number of ongoing smokers. Findings indicated that those who quit experienced a 20% slower rate of memory decline and a 50% slower decline in verbal fluency. Lead author Mikaela Bloomberg, a senior research fellow at University College London, emphasized the importance of cessation efforts for older adults, who are at the highest risk from smoking. While the study strengthens the case for quitting smoking as a means to protect cognitive health, Bloomberg cautioned that further research is needed to explore the potential links to dementia and the biological mechanisms involved. Experts highlight the study's implications for older smokers, suggesting that quitting could be a vital strategy for maintaining cognitive health.
Published: Oct 15 2025, 5 pmeznews.inA recent study presented at the 2025 ECNP Congress has revealed that different types of depression are linked to varying risks of cardiometabolic diseases, including type 2 diabetes and cardiovascular issues. Researchers tracked over 5,700 adults for seven years, finding that those with atypical depression symptoms—characterized by fatigue and increased appetite—were 2.7 times more likely to develop type 2 diabetes. Conversely, participants exhibiting melancholic symptoms, such as insomnia and low appetite, had a 1.5 times greater chance of developing cardiovascular disease. The study, co-led by Dr. Yuri Milaneschi, highlights the complex relationship between mental health and physical well-being, suggesting that distinct biological mechanisms may underlie these associations. Experts emphasize the need for further research to explore these links and develop targeted treatments, as understanding the interplay between depression and metabolic disorders could improve patient outcomes significantly.
Published: Oct 14 2025, 9 pmeznews.inResearchers at the University of East Anglia and Oxford Biodynamics have developed a promising blood test that could revolutionize the diagnosis of chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis (ME). This new test boasts a remarkable 96% accuracy rate, addressing the longstanding challenge of diagnosing a condition often confused with other disorders like fibromyalgia and multiple sclerosis. Currently, CFS lacks a definitive diagnostic test, relying instead on symptom checklists and the exclusion of other diseases. The test examines unique DNA folding patterns in patients, revealing a distinct biological signature absent in healthy individuals. Lead researcher Dmitry Pshezhetskiy emphasized that this advancement could not only streamline diagnosis but also pave the way for targeted therapies. While experts acknowledge the need for further studies to validate the test's effectiveness across broader populations, they express optimism about its potential to provide clarity and support for patients enduring debilitating symptoms.
Published: Oct 13 2025, 10 pmeznews.inA recent study published in *Nature Medicine* suggests that individuals with prediabetes can achieve remission through lifestyle interventions without necessarily losing weight. This challenges existing clinical guidelines that prioritize weight loss as a primary method for preventing the progression to type 2 diabetes. The research found that participants who normalized their blood glucose levels, even with modest weight gain, had a 70% lower risk of developing diabetes over five years compared to those who did not achieve glucose regulation. The study highlights the importance of focusing on improving insulin sensitivity and body fat distribution, particularly reducing visceral fat, rather than solely concentrating on weight loss. Experts advocate for a shift in diabetes prevention guidelines to include targets for glycemic control alongside weight loss goals, emphasizing the role of dietary changes and physical activity in managing prediabetes effectively.
Published: Oct 13 2025, 2 pmeznews.inA recent study has identified five distinct sleep profiles linked to various health traits, emphasizing the complex relationship between sleep quality, brain activity, and overall well-being. Conducted by researchers in Canada and Singapore, the study analyzed data from 770 healthy adults aged 22 to 36, utilizing self-reported questionnaires and MRI scans to explore the connections between sleep patterns and biopsychosocial factors. The profiles range from poor sleep quality associated with mental health issues to resilience in sleep despite daytime impairments. Each profile exhibited unique brain network organizations, suggesting that understanding these patterns could inform tailored interventions for future health issues. Researchers stressed the importance of quality sleep for cognitive function and mental health, recommending strategies such as regular exercise, a comfortable sleeping environment, and consistent sleep schedules. Valeria Kebets, a co-author of the study, highlighted that sleep is vital for daily functioning and urged individuals to address sleep concerns with healthcare providers.
Published: Oct 12 2025, 1 pmeznews.inA recent study has found that daily calcium supplementation does not increase the risk of dementia in older women. Conducted on 1,460 Western Australian women aged 70 and above, the post-hoc analysis of a five-year randomized controlled trial revealed no significant differences in dementia-related hospitalizations or deaths between those taking calcium and those on a placebo. Approximately 18% of participants experienced dementia events, but outcomes were consistent across both groups. While researchers noted limitations, including a lack of data on education levels and potential selection bias, the findings suggest that calcium supplements, commonly used to support bone health, are safe concerning dementia risk. Experts emphasize the need for further research, particularly involving diverse populations and cognitive assessments. Nonetheless, the study offers reassurance to older women who require calcium for osteoporosis prevention, although consulting healthcare providers before starting any supplements is advised.
Published: Oct 11 2025, 1 pmeznews.inEli Lilly's ulcerative colitis treatment, Omvoh, has shown promising results in a recent study, indicating sustained clinical remission for up to four years. The LUCENT-3 trial found that participants who achieved remission after one year maintained their improvement, with 78% remaining corticosteroid-free and 93% reporting reduced bowel urgency. Ulcerative colitis, a chronic inflammatory bowel disease, currently has no cure, making these findings significant for the many patients who do not respond to existing therapies. Dr. Bruce Sands, a leading investigator, emphasized the drug's ability to block interleukin-23, a key inflammatory molecule, thus promoting bowel healing. The FDA approved Omvoh for adults with moderately to severely active ulcerative colitis in 2023. Experts highlighted the importance of long-term data in understanding treatment efficacy and safety, as many patients experience a loss of response over time.
Published: Oct 11 2025, 1 amFor the fastest, latest, not so wokest news, 'experts say' you need to visit Eznews
India
World
Economy
Science
Health
Showbiz
Contact